An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

Inclusion Criteria: 1. Full skin ulcer at lower leg covered with devitalised tissue ≥50% 2. Candidate for cleansing, debridement/desloughing 3. Wound area ≥2 cm² 4. Male or female, 18 years of age and above 5. Able to read and understand the Patient Informed Consent and to provide meaningful written informed consent 6. Able and willing to follow the Protocol requirements Exclusion Criteria: 1. Clinical signs of system progression infection with or without ostemyelitis 2. Wound located where treatment is not possible 3. Subjects not suitable for the investigation according to the investigator's judgment 4. Subjects included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator 5. Known allergy/hypersensitivity to any of the components of the investigational device 6. Pregnant or breast feeding women 7. Other significant medical condition that the investigator determines could interfere with compliance or study assessments 8. Subjects with wounds of duration less than one month 9. Wound area greater than approximately 60 cm²